PRF Technologies (PRFX) Enterprise Value (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Enterprise Value of -$3.4 million for Q4 2025, up 20.35% year-on-year from -$2.8 million in Q4 2024, and up 2.86% on a QoQ basis from -$3.5 million in Q2 2025.
PRF Technologies (PRFX) Enterprise Value (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Enterprise Value for 7 consecutive years, with -$3.4 million the latest figure, recorded in Q4 2025.
- Quarterly Enterprise Value rose 20.35% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.4 million (up 20.35% YoY) and the FY2025 annual result came in at -$3.4 million, up 20.35% from the prior year.
- Enterprise Value grew to -$3.4 million in Q4 2025 per PRFX's latest filing, from -$3.5 million in the prior quarter.
- Over the last five years, Enterprise Value for PRFX reached as high as -$2.8 million in Q2 2024 and fell as low as -$19.4 million in Q1 2021.
- A 5-year average of -$10.2 million and a median of -$8.2 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 3137.09% — and 2023, when it soared 55.57%.
- Year by year, Enterprise Value stood at -$16.5 million in 2021, then surged by 38.44% to -$10.2 million in 2022, then advanced by 21.17% to -$8.0 million in 2023, then surged by 46.91% to -$4.3 million in 2024, then gained by 20.35% to -$3.4 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.4 million, -$3.5 million, and -$4.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Dec 31, 2024 | -4.26 Mn |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -8.03 Mn |
| Sep 30, 2023 | -7.56 Mn |
| Jun 30, 2023 | -6.16 Mn |
| Mar 31, 2023 | -8.15 Mn |
| Dec 31, 2022 | -10.18 Mn |
| Sep 30, 2022 | -12.98 Mn |
| Jun 30, 2022 | -13.87 Mn |
| Mar 31, 2022 | -16.57 Mn |
| Dec 31, 2021 | -16.54 Mn |
| Sep 30, 2021 | -18.34 Mn |
| Jun 30, 2021 | -17.80 Mn |
| Mar 31, 2021 | -19.44 Mn |
| Dec 31, 2020 | -15.68 Mn |
| Sep 30, 2020 | -17.72 Mn |
| Jun 30, 2020 | -550,000.00 |